Assembly Biosciences, Inc. (ASMB)

Longboard Pharmaceuticals Revenue

Assembly Biosciences had revenue of $9.63M in the quarter ending June 30, 2025, with 12.81% growth. This brings the company's revenue in the last twelve months to $33.25M, up 54.77% year-over-year. In the year 2024, Assembly Biosciences had annual revenue of $28.52M with 298.16% growth.

• Revenue (ttm): $33.25M
• Revenue Growth: +54.77%
• P/S Ratio: 4.48
• Revenue / Employee: $455,438
• Employees: 73
• Market Cap: 162.81M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	28.52M	21.36M	298.16%
Dec 31, 2023	7.16M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	6.25M	-72.85M	-92.09%
Dec 31, 2020	79.11M	63.14M	395.55%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.